Autoantibodies to glutamate receptor subunit GluR2 in nonfamilial olivopontocerebellar degeneration

Neurology

Volumn 48, Issue 2, 1997, Pages 494-500

  Gahring, Lorise C ^a,b,c   Rogers, Scott W ^a,b,c   Twyman, Roy E ^b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; AMPA RECEPTOR; AUTOANTIBODY; EPITOPE; GLUTAMATE RECEPTOR; IMMUNOGLOBULIN M; RECEPTOR SUBUNIT; SYNTHETIC PEPTIDE;

ADULT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CASE REPORT; HUMAN; MOUSE; NONHUMAN; OLIVOPONTOCEREBELLAR ATROPHY; PLASMAPHERESIS; PRIORITY JOURNAL; PURKINJE CELL; RECEPTOR BLOCKING;

EID: 0031018689     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.48.2.494     Document Type: Article

References (31)

1. Koningsmark VW, Weiner LP. The olivopontocerebellar atrophies: a review. Medicine 1970;4:227-241.
2. Eadie MJ. Olivopontocerebellar atrophy (Dejerine-Thomas type). In: DeJong JMBV, ed. Handbook of clinical neurology: systems atrophies II. Amsterdam. North Holland, 1991; 16: 511-518.
3. Staal A, DeJong JMBV. Non-familial olivopontocerebellar atrophy. In: DeJong JMBV, ed. Handbook of clinical neurology: systems atrophies II. Amsterdam: North Holland, 1991;16: 519-536.
4. Rosenberg RN, Grossman A. Hereditary ataxia. Neurol Clin 1989;7:25-40.
5. Harding AE. The hereditary ataxias and related disorders. New York: Churchill Livingstone, 1984.
6. Rosenberg RN. The autosomal dominant cerebellar phenotypes: the genotype has settled the issue. Neurology 1995;45: 1-5.
7. Durr A, Chneiweiss H, Khati C, et al. Phenotypic variability in autosomal dominant cerebellar ataxia type I is unrelated to genetic heterogeneity. Brain 1993;110:1497-1508.
8. Nakazaro Y, Yamazaki H, Hirato J, et al. Oligodendroglial microtubular tangles in olivopontocerebellar atrophy. J Neuropathol Exp Neurol 1990;49:521-530.
9. Papp MI, Lantos PL. Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in olivopontocerebellar atrophy. J Neurol Sci 1992;107:172-182.
10. Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988;1:623-634.
11. Young AB, Cha J-HJ, Makoweic RL, Albin RL. Penney JB. The anatomy of the non-N-methyl-D-aspartate excitatory amino acid binding sites in mammalian brain. In: Meldrum BS, Moroni F, Simon RP, Woods JH. eds. Excitatory amino acids. New York: Raven Press, 1991:55-62.
12. Hollmann M, Heinemann SF. Cloned glutamate receptors. Annu Rev Biochem 1994;17:31-108.
13. Hume RI, Dingledine R, Heinemann S. Identification of a site in glutamate receptor subunits that controls calcium permeability. Science 1991;253:1028-1031.
14. Siegel SJ, Janssen WG, Tullai JW, et al. Distribution of the excitatory amino acid receptor subunits GluR2(4) in monkey hippocampus and colocalization with subunits GluR5-7 and NMDAR1. J Neurosci 1995;15:2707-2719.
15. Tolle TR, Berthele A, Zieglgansberger W, Seeburg PH, Wisden W. The differential expression of 16 NMDA and non-NMDA receptor subunits in the rat spinal cord and in periaqueductal gray. J Neurosci 1993;13:5009-5028.
16. Audinat E, Knopfel T, Gahwiler BH. Responses to excitatory amino acids of Purkinje cells and neurons of the deep nuclei in cerebellar slice cultures. J Physiol (Lond) 1990;430:297-313.
17. Rosenmund C, Legendre P, Westbrook G. Expression of NMDA channels on cerebellar Purkinje cells acutely dissociated from newborn rats. J Neurophysiol 1992;68:1901-1905.
18. + entry via AMPA/KA receptors and excitotoxicity in cultured cerebellar Purkinje cells. J Neurosci 1994;14:187-197,
19. Brorson JR, Manzolillo PA, Gibbons SJ, Miller RJ. AMPA receptor desensitization predicts the selective vulnerability of cerebellar Purkinje cells to excitotoxicity. J Neurosci 1995;15: 4515-4524.
20. Rogers SW, Andrews PI, Gahring LC, et al. Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 1994;265:648-652.
21. Twyman RE. Gahring LC, Spiess J, Rogers SW. Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron 1995;14:755-762.
22. Gahring LC, Twyman RE, Greenlee JE, Rogers SW. Autoantibodies to neuronal glutamate receptors in patients with paraneoplastic neurodegenerative syndrome enhance receptor activation. Mol Med 1995;1:245-253.
23. Rogers SW, Twyman RE, Gahring LC. The role of autoimmunity in neurologic disease. Mol Med Today 1996;2:76-81.
24. Rogers SW, Hughes T, Hollmann M, et al. The characterization and localization of the glutamate receptor subunit. GluR1, in the rat brain, J Neurosci 1991;11:2713-2724.
25. Skeen GW, Twyman RE. White HS, The dihydropyridine nitrendipine modulates N-methyl-D-aspartate receptor channel function in mammalian neurons. Mol Pharmacol 1993;44:443-450.
26. Harlow E, Lane D. Antibodies, a laboratory manual. New York: Cold Spring Harbor Laboratory, 1988:308:475-500.
27. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. San Diego: Academic Press, 1986.
28. Tempia F, Kano M, Schneggenburger, et al. Fractional calcium current through neuronal AMPA-receptor channels with low calcium permeability. J Neurosci 1996;16:456-466.
29. Oilman S, Koeppe RA, Junck L, et al. Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy. Ann Neurol 1994;36:166-175.
30. Rinne JO, Burn DJ, Mathias CJ, et al. Positron emission tomography studies on the dopaminergic system and striatal opioid binding in the olivopontocerebellar atrophy variant of multiple system atrophy. Ann Neurol 1995;37:568-573.
31. Penny Jr, JB. Multiple systems atrophy and nonfamilial olivopontocerebellar atrophy are the same disease. Ann Neurol 1995;37:553-554.